Cited by 111Malaria Research and ControlBird parasitology and diseasesPhytochemical compounds biological activities

Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria

Open access
Gowda, DChanne, Dayananda, KiranK, Achur, RajeshwaraN·2018·Journal of Vector Borne Diseases

Abstract

Malaria, caused by the protozoan parasites of the genus Plasmodium, is a major health problem in many countries of the world. Five parasite species namely, Plasmodium falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi, cause malaria in humans. Of these, P. falciparum and P. vivax are the most prevalent and account for the majority of the global malaria cases. In most areas of Africa, P. vivax infection is essentially absent because of the inherited lack of Duffy antigen receptor for chemokines on the surface of red blood cells that is involved in the parasite invasion of erythrocytes. Therefore, in Africa, most malaria infections are by P. falciparum and the highest burden of P. vivax infection is in Southeast Asia and South America. Plasmodium falciparum is the most virulent and as such, it is responsible for the majority of malarial mortality, particularly in Africa. Although, P. vivax infection has long been considered to be benign, recent studies have reported life-threatening consequences, including acute respiratory distress syndrome, cerebral malaria, multi-organ failure, dyserythropoiesis and anaemia. Despite exhibiting low parasite biomass in infected people due to parasite's specificity to infect only reticulocytes, P. vivax infection triggers higher inflammatory responses and exacerbated clinical symptoms than P. falciparum, such as fever and chills. Another characteristic feature of P. vivax infection, compared to P. falciparum infection, is persistence of the parasite as dormant liver-stage hypnozoites, causing recurrent episodes of malaria. This review article summarizes the published information on P. vivax epidemiology, drug resistance and pathophysiology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/0972-9062.234620

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [13]Mueller I, Galinski MR, Tsuboi T, Arevalo-Herrera M, Collins WE, King CL. Chapter Three - Natural Acquisition of Immunity to Plasmodium vivax: Epidemiological Observations and Potential Targets In: Hay RP SI, Baird JK, editors. Advance in parasitol 2013; 77– 131. 23384622
  2. [25]Guidelines for the treatment of malaria. World Health Organization; Geneva 2015 Available from: http://www.who.int/malaria/publications/atoz/9789241549127/en/. 26020088
  3. [59]Carvalho BO, Lopes SCP, Nogueira PA, Orlandi PP, Bargieri DY, Blanco YC, On the Cytoadhesion of Plasmodium vivax–Infected Erythrocytes. J Infect Dis 2010; 202(4): 638– 47. 20617923
  4. [62]Yeo TW, Lampah DA, Tjitra E, Piera K, Gitawati R, Kenangalem E, Greater Endothelial Activation, Weibel-Palade Body Release and Host Inflammatory Response to Plasmodium vivax, compared with Plasmodium falciparum: A Prospective Study in Papua, Indonesia. J Infect Dis 2010; 202(1): 109– 12. 20497057 PMC4313368

Cited by

Sorted by citations

Authors
Gowda, D., Dayananda, K., & Achur, R.
Affiliations
  • Pennsylvania State University (US)
  • Nitte University (IN)
Corresponding author
Gowda, DChanne
Venue
Journal of Vector Borne Diseases
Published
2018
Volume
55
Issue
1
Pages
1
ISSN
0972-9062 (ISSN-L)
OpenAlex
W2809613680
Cited by
111
References
105
Citations by year
2026: 10 · 2025: 11 · 2024: 15 · 2023: 24 · 2022: 12 · 2021: 27 · 2020: 7 · 2019: 4 · 2018: 1
FWCI
1.77
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Journal of Vector Borne Diseases (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institute of Allergy and Infectious Diseases (R01AI041139)
  • Fogarty International Center (D43TW008268)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Life Sciences › Immunology and Microbiology › Parasitology › Bird parasitology and diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phytochemical compounds biological activities
Keywords
Plasmodium vivax, vivax malaria, Plasmodium falciparum, malaria epidemiology, antimalarial drug resistance, malaria pathophysiology, hypnozoites, recurrent malaria, cerebral malaria, anemia, inflammation
MeSH terms
Antimalarials, Asia, Southeastern, Drug Resistance, Female, Humans, Inflammation, Liver, Male, Plasmodium vivax, Pregnancy, Recurrence, South America, Pregnancy Complications, Parasitic, Malaria, Vivax

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review